120 related articles for article (PubMed ID: 9315094)
21. Interferon-gamma signaling in human retinal pigment epithelial cells mediated by STAT1, ICSBP, and IRF-1 transcription factors.
Li W; Nagineni CN; Hooks JJ; Chepelinsky AB; Egwuagu CE
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):976-82. PubMed ID: 10102295
[TBL] [Abstract][Full Text] [Related]
22. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
Marecki S; Atchison ML; Fenton MJ
J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
[TBL] [Abstract][Full Text] [Related]
23. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
[TBL] [Abstract][Full Text] [Related]
24. Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription.
Saura M; Zaragoza C; Bao C; McMillan A; Lowenstein CJ
J Mol Biol; 1999 Jun; 289(3):459-71. PubMed ID: 10356322
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of celtix-1, a bromodomain protein interacting with the transcription factor interferon regulatory factor 2.
Staal A; Enserink JM; Stein JL; Stein GS; van Wijnen AJ
J Cell Physiol; 2000 Nov; 185(2):269-79. PubMed ID: 11025449
[TBL] [Abstract][Full Text] [Related]
26. Involvement of nucleophosmin/B23 in the cellular response to curcumin.
Weng CH; Yung BY; Weng JJ; Wu MH
J Nutr Biochem; 2011 Jan; 22(1):46-52. PubMed ID: 20303727
[TBL] [Abstract][Full Text] [Related]
27. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1.
Tanaka N; Ishihara M; Kitagawa M; Harada H; Kimura T; Matsuyama T; Lamphier MS; Aizawa S; Mak TW; Taniguchi T
Cell; 1994 Jun; 77(6):829-39. PubMed ID: 8004672
[TBL] [Abstract][Full Text] [Related]
28. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2.
Harada H; Kitagawa M; Tanaka N; Yamamoto H; Harada K; Ishihara M; Taniguchi T
Science; 1993 Feb; 259(5097):971-4. PubMed ID: 8438157
[TBL] [Abstract][Full Text] [Related]
29. IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo.
Kim PK; Armstrong M; Liu Y; Yan P; Bucher B; Zuckerbraun BS; Gambotto A; Billiar TR; Yim JH
Oncogene; 2004 Feb; 23(5):1125-35. PubMed ID: 14762441
[TBL] [Abstract][Full Text] [Related]
30. Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1.
Tanaka N; Ishihara M; Taniguchi T
Cancer Lett; 1994 Aug; 83(1-2):191-6. PubMed ID: 8062214
[TBL] [Abstract][Full Text] [Related]
31. Expression of interferon regulatory factor 1 and 2 in hematopoietic cells of children with juvenile myelomonocytic leukemia.
Mild GC; Schmahl GE; Shayan P; Niemeyer CM
Leuk Lymphoma; 1999 Nov; 35(5-6):507-11. PubMed ID: 10609788
[TBL] [Abstract][Full Text] [Related]
32. Over-expression of nucleophosmin/B23 decreases the susceptibility of human leukemia HL-60 cells to retinoic acid-induced differentiation and apoptosis.
Hsu CY; Yung BY
Int J Cancer; 2000 Nov; 88(3):392-400. PubMed ID: 11054668
[TBL] [Abstract][Full Text] [Related]
33. Interferon regulatory factor expression in human breast cancer.
Doherty GM; Boucher L; Sorenson K; Lowney J
Ann Surg; 2001 May; 233(5):623-9. PubMed ID: 11323500
[TBL] [Abstract][Full Text] [Related]
34. DIGE-based proteomic analysis identifies nucleophosmin/B23 and nucleolin C23 as over-expressed proteins in relapsed/refractory acute leukemia.
Hu J; Lin M; Liu T; Li J; Chen B; Chen Y
Leuk Res; 2011 Aug; 35(8):1087-92. PubMed ID: 21310483
[TBL] [Abstract][Full Text] [Related]
35. Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases.
Colombo E; Alcalay M; Pelicci PG
Oncogene; 2011 Jun; 30(23):2595-609. PubMed ID: 21278791
[TBL] [Abstract][Full Text] [Related]
36. UV stimulation of nucleophosmin/B23 expression is an immediate-early gene response induced by damaged DNA.
Wu MH; Yung BY
J Biol Chem; 2002 Dec; 277(50):48234-40. PubMed ID: 12374805
[TBL] [Abstract][Full Text] [Related]
37. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.
Willman CL; Sever CE; Pallavicini MG; Harada H; Tanaka N; Slovak ML; Yamamoto H; Harada K; Meeker TC; List AF
Science; 1993 Feb; 259(5097):968-71. PubMed ID: 8438156
[TBL] [Abstract][Full Text] [Related]
38. Expression patterns among interferon regulatory factor-1, human X-box binding protein-1, nuclear factor kappa B, nucleophosmin, estrogen receptor-alpha and progesterone receptor proteins in breast cancer tissue microarrays.
Zhu Y; Singh B; Hewitt S; Liu A; Gomez B; Wang A; Clarke R
Int J Oncol; 2006 Jan; 28(1):67-76. PubMed ID: 16327981
[TBL] [Abstract][Full Text] [Related]
39. Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer.
Nozawa H; Oda E; Ueda S; Tamura G; Maesawa C; Muto T; Taniguchi T; Tanaka N
Int J Cancer; 1998 Aug; 77(4):522-7. PubMed ID: 9679752
[TBL] [Abstract][Full Text] [Related]
40. The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells.
Sers C; Husmann K; Nazarenko I; Reich S; Wiechen K; Zhumabayeva B; Adhikari P; Schröder K; Gontarewicz A; Schäfer R
Oncogene; 2002 Apr; 21(18):2829-39. PubMed ID: 11973642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
